Systeme und Verfahren zur Rückführung Behandelter Mononuklearer Zellen in eine Blooo-Quelle
Anmelder: Fenwal, Inc. 🇺🇸
Details
- Veröffentlichungs-Nr.
- EP3461510
- Aktenzeichen
- EP18196602
- Anmeldetag
- 25. September 2018
- Veröffentlichung
- 27. April 2022
- Erteilung
- 27. April 2022
- Rechtsraum
- EP
- IPC
- A61M1/02A61M1/36A61M1/38
Abstract
A system for treating mononuclear cells for an extracorporeal photopheresis procedure, driven and adjusted by a microprocessor-based controller. A fluid circuit is primed with priming fluid. Whole blood derived from a blood source is directed into the fluid circuit.The whole blood is separated into a red blood cell component, a mononuclear cell component, and a plasma component. A first portion of the red blood cell component and a first portion of the plasma component are returned to the whole blood. A photoactivation agent is added to the mononuclear cell component to create an agent-added mononuclear cell component. The agent-added mononuclear cell component is irradiated to create a photoactivated mononuclear cell component. A first portion of the photoactivated mononuclear cell component is incubated for a period of time to create an incubated photoactivated mononuclear cell component.
Anmelder
- Firma
- Fenwal, Inc.
- Land
- 🇺🇸 USA
US-amerikanisches Medizintechnikunternehmen mit Fokus auf Blutmanagement. Fenwal entwickelt Geräte und Verbrauchsmaterialien für Blutspende, Bluttrennung und Bluttransfusionstechnik.
407 Patente in unserer Datenbank